Initial Approach to the HIV-Infected Patient - PowerPoint PPT Presentation

1 / 45
About This Presentation
Title:

Initial Approach to the HIV-Infected Patient

Description:

... Cryptococcal lesions Kaposi sarcoma Bacillary angiomatosis Herpes simplex Cheilosis/Chelitis Eosinophilic folliculitis Human papilloma virus Molluscum ... – PowerPoint PPT presentation

Number of Views:414
Avg rating:3.0/5.0
Slides: 46
Provided by: tne88
Category:

less

Transcript and Presenter's Notes

Title: Initial Approach to the HIV-Infected Patient


1
Initial Approach to the HIV-Infected Patient
Ronald Wilcox Delta AETC
2
Objectives
  • Summarize the key elements of the intake history
    and physical exam of a new HIV positive patient
  • Review laboratory and other studies pertinent to
    the care of a new HIV positive patient
  • Discuss early treatment decisions that may be
    required

3
HIV Infection- A Chronic Disease
Inpatient Management
Serologic OI HAART
Testing Prophylaxis

Outpatient Management
4
Testing for HIV Infection
  • Implications of testing
  • Who should be tested
  • How to test

5
Implications of HIV Testing
Pre-test Counseling
Testing
Post-test Counseling
6
How to Test for HIV Infection
  • ELISA screen for chronic infection
  • Western Blot confirm chronic infection
  • Indirect Immunofluorescence Assay
  • Viral Nucleic Acid Detection - RNA PCR
    screen for acute infection - cDNA PCR
    screen for perinatal infection - bDNA
  • p24 antigen confirmation of acute infection
  • Rapid HIV Screens

7
Initial Approach to the HIV-Infected Patient
  • Data Collection
  • Patient Education
  • Early Treatment Decisions

8
Data Collection
  • History
  • Physical Exam
  • Laboratory and other clinical studies

9
Intake History
  • Details of HIV testing
  • When? Why? Previous negative test?
  • HIV specific symptoms
  • Fever, night sweats, weight loss, lymphadenopathy
  • Symptoms indicative of HIV-associated illness
  • History of tuberculosis exposure
  • History of STDs
  • Gynecologic history in females

10
Intake History
  • ALL medications include alternative, herbal ,
    and OTC medications as well as contraception
  • Immunization history
  • HIV transmission category and risk factors
  • MSM vs IVDU vs known heterosexual exposure vs
    blood transfusion
  • Social habits
  • Travel history
  • ROS directed towards symptoms indicative of
    HIV-associated illnesses

11
Question
  • Which of the following supplements is
    CONTRA-INDICATED with anti-retroviral therapy?
  • 1. Gingko baloba
  • 2. Creatine
  • 3. Vitamin C
  • 4. St. Johns Wort

12
LA StatisticsExposure Category for People Newly
Diagnosed with HIV/AIDS in 2007 (06/30/08)
13
Question
  • Which of the following is NOT a cutaneous
    manifestation of HIV disease?
  • 1. Psoriasis
  • 2. Sebhorreic dermatitis
  • 3. Chelosis
  • 4. Bacillary angiomatosis
  • 5. Eosinophilic folliculitis

14
Cutaneous Manifestations of HIV Infection
  • Rash of acute retroviral syndrome
  • Histoplasmosis
  • Scabies
  • Multi-dermatomal herpes zoster
  • Sebhorreic dermatitis
  • Cryptococcal lesions
  • Kaposi sarcoma
  • Bacillary angiomatosis
  • Herpes simplex
  • Cheilosis/Chelitis
  • Eosinophilic folliculitis
  • Human papilloma virus
  • Molluscum contagiosum

15
Cutaneous Manifestations
Histoplasma
Cryptococcus
ARS
Scabies
Kaposi Sarcoma
Bacillary Angiomatosis
16
Oropharyngeal Manifestations of HIV Infection
  • Necrotizing Ulcerative Periodontitis
  • Kaposi Sarcoma
  • Mucosal Ulcerations
  • Candida
  • Histoplasmosis
  • Syphilis
  • Herpes simplex
  • Cytomegalovirus
  • Aphthous
  • Non-Hodgkin Lymphoma
  • Oral Squamous Cell Carcinoma
  • Human Papilloma Virus
  • Bacillary Angiomatosis
  • Oral Hairy Leukoplakia
  • Candidiasis

17
Oropharyngeal Manifestations
Necrotizing Ulcerative Periodontitis
Kaposi Sarcoma
Non-Hodgkin Lymphoma
Mucosal Ulceration
18
Ophthalmologic Manifestations of HIV Infection
  • Progressive Outer Retinal Necrosis
  • Cytomegaloviral retinitis
  • Toxoplasmic chorioretinitis

19
Ophthalmologic Manifestations
Toxoplasma Chorioretinitis
Progressive Outer Retinal Necrosis
Cytomegaloviral Retinitis
20
Genitourinary Complications Related to HIV
Infection
  • Sexually transmitted infections
  • Herpes Simplex
  • Human Papilloma Virus
  • Syphilis
  • Gonorrhea
  • Chlamydia
  • Trichomonas
  • Vaginal aphthous ulcerations
  • Cervical and Rectal Cancer

21
Genitourinary Complications Related to HIV
Infection
Anogenital Warts
22
Question
  • An HIV positive patient with a CD4 count of 5 on
    no medications except TMP/SMX (Bactrim) presents
    to the Emergency Room after a seizure.
  • What is the most likely cause of the seizure?
  • 1. Toxoplasmosis
  • 2. Staphylococcus aureus abscess
  • 3. Non-Hodgkin Lymphoma
  • 4. Progressive Multifocal Leukoencephalopathy
  • 5. HIV Encephalopathy

23
Neurologic Manifestations of HIV Infection
  • Peripheral neuropathy
  • HIV-Associated Dementia
  • HIV encephalopathy
  • HSV encephalitis
  • Aseptic meningitis
  • Vacuolar myelopathy
  • TB meningitis
  • Progressive Multifocal Leukoencephalopathy
  • HIV Cephalgias
  • Brain Mass Lesions
  • MAGIC
  • Metastases
  • Abscesses (toxoplasma, fungal, mycobacterial,
    bacterial)
  • Glioma
  • Infections (PML, CMV)
  • Cancer (NHL) or Cysts

24
Significant Symptom Review
  • Fever, weight loss, fatigue
  • Disseminated MAC
  • Fever, weight loss, fatigue, rash
  • Disseminated histoplasmosis

25
Significant Symptom Review
  • Headache slowly progressive with fever
  • Cryptococcal meningitis
  • Tuberculous meningitis
  • Seizure
  • Cerebral toxoplasmosis
  • Primary CNS Lymphoma

26
Significant symptom review
  • Shortness of breath gradual non-porductive
    cough or clear to white sputum
  • Pneumocystis jirovecii (PcP)
  • Productive cough, weight loss, hemoptysis
  • Tuberculosis

27
Laboratory Studies- ALL Patients
  • CD4 cell count
  • HIV viral load
  • CBC with differential
  • Chemistry panel
  • VDRL or RPR and other STD testing
  • Hepatitis A, B, and C serology

28
CD4 Cell Count
  • Stage disease
  • Determine the risk of HIV-associated
    complications
  • Determine the need for opportunistic infection
    prophylaxis
  • Guide decision making regarding antiviral therapy

29
CD4 cell count can vary substantially and is
affected by
  • Concomitant use of corticosteroids
  • Intercurrent illness
  • Co-infection with HTLV-I
  • Variation of other components of the WBC count
  • Splenectomy

30
HIV Viral Load
  • Assess prognosis
  • Determine the need for antiviral therapy
  • Guide choice of antiviral regimen
  • Assess response to therapy

31
HIV Viral Load
  • RNA PCR
  • bDNA
  • HIV Viral Load can be affected by
  • Intercurrent illness
  • Recent vaccination

32
Question
  • All of the following are increased in the
    HIV-infected patient EXCEPT
  • 1. Thrombocytopenic thrombotic purpura (TTP)
  • 2. Idiopathic thrombocytopenic purpura (ITP)
  • 3. Anemia of chronic disease
  • 4. Iron-deficiency anemia
  • 5. Lymphopenia
  • 6. Neutropenia

33
Laboratory Studies- ALL Patients
  • Anti-toxoplasma IgG
  • Urinalysis
  • TB skin test (or chest x-ray)
  • Pap smear in women
  • HIV Resistance Testing in Patients not currently
    controlled on medications and ALL treatment-naïve
    patients

34
HIV Resistance in Naïve Pts
  • Test to order genotype
  • 15-40 of those newly diagnosed have baseline
    resistance
  • Only do if never on meds before or currently on
    meds and viral load gt 1500.

35
Question
  • Urinalysis is done in the HIV-infected patient to
    screen for HIV-associated nephropathy (HAN).
    Which is the best indicator for the possible
    presence of HAN?
  • 1. Proteinuria
  • 2. Crystalluria
  • 3. Hematuria
  • 4. Pyuria (WBC in the urine)
  • 5. Low specific gravity

36
Question
  • Urinalysis is done in the HIV-infected patient to
    screen for HIV-associated nephropathy (HAN).
    Which is the best indicator for the possible
    presence of HAN?
  • 1. Proteinuria Focal Segmental
    Glomerulosclerosis
  • 2. Crystalluria
  • 3. Hematuria IgA Nephropathy
  • 4. Pyuria (WBC in the urine)
  • 5. Low specific gravity

37
Laboratory Studies- CONSIDER
  • Repeat HIV serology
  • Anti-varicella IgG
  • G-6-PD level
  • Anal PAP smears
  • HTLV 1,2 Antibodies
  • Fasting lipid profile
  • Morning testosterone level
  • Chest radiograph
  • HLA-B5701

38
Patient Education
  • Natural history of HIV infection
  • Health maintenance issues
  • Nutrition counseling
  • Transmission of HIV and risk assessment
  • Partner notification
  • Social support evaluation
  • Mental health assessment

39
Early Treatment Decisions
  • Immunizations
  • Highly Active Antiretroviral Therapy
  • Opportunistic infection prophylaxis

40
Immunizations
  • Optimally give when immune response most likely
  • Early before immune deterioration
  • After immune recovery on HAART

41
Question
  • Which of the following immunizations would be
    contra-indicated in a patient with AIDS?
  • 1. Td
  • 2. Pneumovax
  • 3. Influenza
  • 4. Hepatitis A
  • 5. MMR

42
Immunizations-Avoid Live Vaccines
  • BCG
  • MMR
  • Varicella-zoster
  • Oral polio
  • Oral typhoid
  • Yellow fever

43
Routine Immunizations for HIV-Infected Patients
  • Pneumococcal
  • Influenza
  • Hepatitis B begin after CD4 count gt 200 and
    viral load suppressed
  • Hepatitis A
  • Tetanus-Diphtheria

44
Summation
  • Approach to newly diagnosed HIV patient is
    similar to all patients but must specifically
    look at
  • Signs or symptoms of opportunistic infections
  • Unusual lab work-up including CD4 counts and
    viral loads and genotypes
  • Avoidance of live viral vaccines
  • Determine need for OI prophylaxis while waiting
    for evaluation by HIV expert

45
Question
  • As compared to how I felt before the presentation
    on evaluating newly diagnosed HIV-infected
    people, I now feel
  • 1. Much more comfortable
  • 2. A little more comfortable
  • 3. About the same
  • 4. A little more leery
  • 5. I will not see patients with HIV in the future
Write a Comment
User Comments (0)
About PowerShow.com